London, UK – 07 August 2019 – Instinctif Partners, the international business communications consultancy, congratulates all nominees shortlisted as finalists for the 2019 OBN Awards.
The OBN Awards, which are now in their 11th year, celebrate achievement in the UK life sciences industry, from outstanding scientific innovation within biotech, medtech, digital and synthetic biology, to the companies and organisations that support the industry.
Particular congratulations go to the two clients of the Instinctif Partners Life Sciences’ practice who have been announced as finalists: Astex Pharmaceuticals (for Best Established Biotech Company) and Congenica (for Best Established Medtech Company).
The full list of award categories and finalists, as well as further information on the awards, can be found here: https://www.obn-awards.com/. The winners will be announced at the OBN Awards evening on Thursday 7 November at the Examination Schools in Oxford.
Commenting on the announcement, Sue Charles, Managing Partner of Instinctif Partners Life Sciences’ practice, BIA Board Member and OBN Awards Judging Panel member, said:
“The OBN Awards have grown to become one of the most prestigious awards events in the UK life sciences industry and provide a great opportunity to highlight the outstanding progress, innovation and achievements seen within the sector over the past year. We would like to congratulate all shortlisted companies for reaching the final stage of these competitive awards and I look forward to the Awards dinner and to congratulating the winner in each category.”
About Instinctif Partners Life Sciences
Instinctif Partners is a leading international business communications consultancy and has recently been awarded International Agency of the Year at the PR Week Global Awards 2017. The firm has an exceptionally strong dedicated team focused in the Life Sciences sector. This Life Sciences practice has expertise across financial, corporate, healthcare and marketing communications, and integrates design and digital into its communications mix. Offering global outreach, its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit, academic organisations and science-associated bodies.
Sue CharlesManaging Partner